Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers - Wikidata - wikimedia - TriplyDB

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers

http://www.wikidata.org/entity/Q34764884

about

Breast cancer risk factors The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model.Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal women Educational differences in postmenopausal breast cancer--quantifying indirect effects through health behaviors, body mass index and reproductive patterns.Circulating sex hormones and terminal duct lobular unit involution of the normal breast.An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial Premenopausal serum androgens and breast cancer risk: a nested case-control study.Does estrogen play a role in response to adjuvant bone-targeted therapies?Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up.Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial.CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment.Sex hormone levels and risk of breast cancer with estrogen plus progestin.Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women Trends in breast cancer incidence and mortality in the United States: implications for prevention.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Pitaya Extracts Induce Growth Inhibition and Proapoptotic Effects on Human Cell Lines of Breast Cancer via Downregulation of Estrogen Receptor Gene Expression.Relationship between dietary carbohydrates intake and circulating sex hormone-binding globulin levels in postmenopausal women.Clinical implications of estrone sulfate measurement in laboratory medicine.Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women.PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer.Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.Breast density influences tumor subtypes and tumor aggressiveness.Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.Evaluation of a sex hormone-binding globulin automated chemiluminescent assay.Levels of miRNA and Hormones in Thoracic Duct Lymph in Rats with Experimental Breast Cancer Induced by N-Methyl-N-Nitrosourea.Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients.Pituitary, Gonadal, Thyroid Hormones and Endocrine Disruptors in Pre and Postmenopausal Nigerian Women with ER-, PR- and HER-2-Positive and Negative Breast Cancers.Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy

P2860

Q26777289-C9CD3693-2D22-47D2-B01C-DAF9B9DBA381 Q26799120-79240B30-AAAB-48F3-93A6-C399F40D1B54 Q33892734-BEE4E6CC-63F5-4DA9-A091-B20928E363C6 Q33949822-4BE379F7-1019-45AB-A6F7-7A168C973098 Q34043711-A23BF6F0-9F80-45F5-B1AB-25452A7736D9 Q34198265-92E8F540-5789-4C65-8D5B-9B98708A8C2C Q34642072-4EC344C5-AD7E-4780-888C-433D84FD304C Q35036644-EF6BCCFF-A877-4858-8AAB-B4DE6B92B885 Q35098777-5A83E64C-9135-4633-9B9E-8DDFDB114485 Q35691630-F80083E9-C772-458F-B1E0-74087038E978 Q36385015-91C9291F-AC6A-41D2-86EF-A44FFD266398 Q36393224-6FB64AE7-41C5-4B96-9219-613396F5BD52 Q36491529-E3033B62-3A78-4C69-9FB4-5413FCC3A1B5 Q36638994-418879C2-DD4B-4412-8BEC-13DB099CAB3D Q36642745-D9EFF539-1DFE-4084-962E-C82A7407E920 Q36910418-43ECF4EE-6778-437C-B2AA-39C061CAB0FD Q36962516-FC161E2A-3B93-4683-AB80-3471ECDAB849 Q37209551-6BC1243B-8886-49E7-898F-18DCE4C680AD Q37380757-ED3B8261-1EB0-4279-B4A5-D5B31E58DFAB Q37533025-8F1EB635-A480-4074-9E63-861645A85E7B Q37656401-16D67BD7-2E46-41C2-873C-C651F228D3BF Q38094973-0BDD48AA-30A9-470D-A257-2C9F623CF288 Q38097730-DFB7B445-43DC-47A4-AAA6-65EC61B26D4E Q38696028-2F2AFD31-E4AC-4213-9D5B-1B6705BD12EF Q38743686-F1DE4751-8DAF-4651-81C6-A14159AFBE70 Q39037694-6A71EA36-42C9-4678-BA2E-5338057FEFBE Q39043672-8C06DAD1-46E9-4BEF-A35E-E97E5DB74A66 Q40089754-FE8608EB-702B-4866-BA73-729980B54D78 Q40409564-2F6AA5A2-F8FB-4C42-8DFA-67769874867C Q42378354-CB530063-24A8-47A9-B46F-5824853C4627 Q42511496-661DCE08-9CD8-41A3-B395-D43B19262522 Q42516409-03718558-BD13-4C6C-82F4-9AEF350AA8D0 Q42852622-9CA2DDBE-3DC2-4846-B905-9EA5D3085948 Q43408154-02D6E8DB-850E-4C0B-B683-08DF2CD98EE9 Q44041311-14CCF19F-1243-42B2-9839-715C001F70B7 Q51188736-8AD018B4-2174-49A1-B333-F673FBA8E15D Q55302514-AD7A345A-2C02-42EC-9617-D52188432364 Q55439552-78756C92-BC68-4B1A-884A-24C623025B42 Q58871224-9522FB77-9C32-4788-AF3B-2D1DE0D4F8B5

P2860

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers

http://www.wikidata.org/entity/Q34764884

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@ast

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@en

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@nl

type

label

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@ast

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@en

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@nl

prefLabel

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@ast

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@en

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@nl

P1433

Q34764884-FB5CE67F-CB3F-4F61-BB9C-40D468A4AA28

P1476

Q34764884-5B69FD06-B5FE-45CB-9B91-A05DD85CB0D4

P2093

Q34764884-096C9D34-DD2D-4849-A88F-0241F5C25053

Q34764884-1ABCFDF7-9914-4D23-8E5A-299473039479

Q34764884-2082FB86-5DCF-42AC-B4D2-F4F0CFD774FE

Q34764884-23557016-CB11-4BCA-A7CF-5022293DFDB4

Q34764884-24352E0E-22AB-4D17-9D24-C08FDFB634A7

Q34764884-2EE8A431-F4EA-494B-96AB-39FD5A090F76

Q34764884-5D8CE054-2BC4-484F-92C4-DC791055860B

Q34764884-64E8F953-D3A9-4C7B-9315-E31F4F475AAC

Q34764884-899C6339-66FE-42EB-B0FF-4C4B9218102E

Q34764884-906FB65A-2D81-4E04-BE91-1021079BB16E

P2860

Q34764884-1500042D-085A-4A67-AB40-E4B08F98A889

Q34764884-19A03565-07E4-4EFF-B5A1-BCCB58CF8403

Q34764884-1D3C389B-CE6B-4337-844D-CC2228678B10

Q34764884-1FFE3749-A2AA-45FB-8992-CA01EC3C94A5

Q34764884-2159A45A-B329-4ACF-B240-466C067D1F66

Q34764884-28240A01-3498-4FB5-A33E-49312C9762BB

Q34764884-44DC33FF-40AB-40E5-9EF4-D861595669B4

Q34764884-4F8473C4-C06F-4551-927F-9A6B7439189B

Q34764884-543907F5-CFF4-42D2-B349-044E7CA544C1

Q34764884-58C6A573-5459-4FF9-A12E-3DC17C33695B

P304

Q34764884-1ACB641B-4C66-4CF7-9632-F99B68580112

P31

Q34764884-091960DF-1E22-424E-B874-9FD4F1A9A297

P356

Q34764884-94678D63-5F3D-4437-8CB9-BFC105C5E8E9

P407

Q34764884-641BB716-AA09-4A0C-86B4-AC03C3FB3FA1

P433

Q34764884-4AD1AB27-C1A0-48D8-9964-43C14D5194E8

P478

Q34764884-5D53D2D1-25A9-45B4-97C6-9758EFF78CB0

P50

Q34764884-E3CC2B2C-674E-4D4D-A9DE-37BBF5159E98

P577

Q34764884-D1D23685-D8CD-4409-9956-CBAD7D2970E2

P5875

Q34764884-EF6D4DFA-F3B5-4070-9DD7-C0E236ACAC3D

P698

Q34764884-38F92F9B-61DE-4AC1-ABD7-CDC52CBC2A51

P932

Q34764884-0A2A2C7D-ABA3-404B-9673-F0A33A5FAC1A

P356

P1433

Journal of the National Cancer Institute

P1476

Sex hormone levels and risks o ...... ceptor-positive breast cancers

@en

P2093

Alison J Huang

http://www.w3.org/2001/XMLSchema#string

Barbara B Cochrane

http://www.w3.org/2001/XMLSchema#string

Dorothy S Lane

http://www.w3.org/2001/XMLSchema#string

F Allan Hubbell

http://www.w3.org/2001/XMLSchema#string

Ghada N Farhat

http://www.w3.org/2001/XMLSchema#string

Jennifer S Lee

http://www.w3.org/2001/XMLSchema#string

Joann E Manson

http://www.w3.org/2001/XMLSchema#string

Mara Vitolins

http://www.w3.org/2001/XMLSchema#string

Neeta Parimi

http://www.w3.org/2001/XMLSchema#string

Rowan T Chlebowski

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk

Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats.

Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression.

A physiologic role for testosterone in limiting estrogenic stimulation of the breast.

Testosterone for low libido in postmenopausal women not taking estrogen.

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study

Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study

Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

P304

562-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJR031

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49845021

http://www.w3.org/2001/XMLSchema#string

P698

21330633

http://www.w3.org/2001/XMLSchema#string

P932

3071353

http://www.w3.org/2001/XMLSchema#string